AI assistant
Sending…
SIGA TECHNOLOGIES INC — Director's Dealing 2008
Dec 17, 2008
32600_dirs_2008-12-17_46f414ad-5f2e-47b7-90b0-73f0bbffcc65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SIGA TECHNOLOGIES INC (SIGA)
CIK: 0001010086
Period of Report: 2008-12-15
Reporting Person: ROSE ERIC A MD (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-12-15 | Common Stock, par value $.0001 per share | P | 9200 | $3.06 | Acquired | 1330680 | Direct |
| 2008-12-15 | Common Stock, par value $.0001 per share | P | 9200 | $3.06 | Acquired | 1339880 | Indirect |
Footnotes
F1: Includes 1,220,000 shares of common stock issuable upon exercise of options. Does not include shares of common stock that Dr. Rose, as a director of TransTech Pharma, may be deemed to beneficially own and as to which Dr. Rose disclaims beneficial ownership.
More from SIGA TECHNOLOGIES INC
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Jan 28
Regulatory Filings
2025
Nov 10
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Regulatory Filings
2025
Aug 8
Interim / Quarterly Report
2025
Aug 5
Earnings Release
2025
Aug 5